NCT05774184Phase 2Completed

A Study of CDX-0159 in Patients With Eosinophilic Esophagitis

Study sponsor: Celldex Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-06-04Actual
Enrollment · participants86Actual
Source updated2026-05-27Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview